Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Exagen Inc
About XGN
Exagen Inc. is a provider of autoimmune diagnostics focused on transforming care for patients with chronic and debilitating autoimmune conditions. The Company is focused on the design, development and commercialization of a portfolio of testing products under its AVISE brand, which allow for the differential diagnosis, prognosis and monitoring of complex rheumatic, autoimmune and autoimmune-related disease including, among others, systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). Its testing products are supported by two proprietary technologies: its AVISE Lupus platform, which incorporates Cell-Bound Complement Activation Products (CB-CAPs) for diagnosing SLE, and a set of three biomarkers, the t-cell-based CB-CAP TC4d, along with two t-cell antibodies, TIgG, and TIgM (the T-Cell Biomarkers), all of which are incorporated into its AVISE CTD product. The Company’s flagship product, AVISE CTD, enables clinicians to more effectively diagnose complex autoimmune conditions.
Find out what a historical investment in Exagen Inc would be worth today using our XGN stock calculator.
Market Capitalisation
$87.94M
Price-earnings ratio
-
Dividend yield
0.00%
Volume
291.33K
High today
$3.85
Low today
$3.61
Open price
$3.75
52-week high
$12.23
52-week low
$2.59
Ready to start your investing journey with Stake?
Open an accountHow do I buy XGN shares in Australia?
Buying XGN shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Exagen Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in XGN
What is the ticker symbol of Exagen Inc?
The ticker symbol for Exagen Inc is XGN.
How much is one share of XGN?
One share of XGN is valued at $3.63 as of 17 May 2026.
What is the market capitalisation of Exagen Inc XGN?
As of 17 May 2026 Exagen Inc has a market cap of $87.94M.
What is the 52-week high for Exagen Inc stock?
The Exagen Inc 52-week high stock price is $12.23.
What is the 52-week low for Exagen Inc stock?
The Exagen Inc 52-week low stock price is $2.59.
Can I buy XGN shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy XGN shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in XGN on Stake
- Buy XGN from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of XGN from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
XGN related stocks